Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson’s disease

The diagnosis of Parkinson’s disease (PD) occurs after pathogenesis is advanced and many substantia nigra (SN) dopamine neurons have already died. Now that therapies to block this neuronal loss are under development, it is imperative that the disease be diagnosed at earlier stages and that the respo...

Descripción completa

Detalles Bibliográficos
Autores principales: Sulzer, David, Cassidy, Clifford, Horga, Guillermo, Kang, Un Jung, Fahn, Stanley, Casella, Luigi, Pezzoli, Gianni, Langley, Jason, Hu, Xiaoping P., Zucca, Fabio A., Isaias, Ioannis U., Zecca, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893576/
https://www.ncbi.nlm.nih.gov/pubmed/29644335
http://dx.doi.org/10.1038/s41531-018-0047-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893576/
https://www.ncbi.nlm.nih.gov/pubmed/29644335
http://dx.doi.org/10.1038/s41531-018-0047-3

Ejemplares similares